Macrogenics Inc. (MGNX)
NASDAQ · Healthcare
Macrogenics Inc. Operating Income 2011–2025
Macrogenics Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Macrogenics Inc. operating income for the quarter ending March 31, 2026 was -33.4 M, a 21.55% decrease year-over-year.
- Macrogenics Inc. operating income for the twelve months ending March 31, 2026 was -94.2 M, a 1.01% increase year-over-year.
- Macrogenics Inc. annual operating income for 2025 was -72.8 M, a 34.13% decrease from 2024.
- Macrogenics Inc. annual operating income for 2024 was -110.6 M, a 34.28% decrease from 2023.
- Macrogenics Inc. annual operating income for 2023 was -168.2 M, a 38.57% increase from 2022.
- Macrogenics Inc. annual operating income for 2022 was -121.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Macrogenics Inc. Operating Income — FAQ
Macrogenics Inc. (MGNX) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Macrogenics Inc.'s operating income?
Macrogenics Inc. (MGNX) reported operating income of -$73M for fiscal 2025.
Where can I see MGNX's operating income history?
The chart and table above show Macrogenics Inc.'s operating income by year and by quarter, including the growth rate.